nach oben

Erschienen in:

23.06.2016 | Article

CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion

verfasst von: Mia Abels, Matteo Riva, Hedvig Bennet, Emma Ahlqvist, Oleg Dyachok, Vini Nagaraj, Liliya Shcherbina, Rikard G. Fred, Wenny Poon, Maria Sörhede-Winzell, Joao Fadista, Andreas Lindqvist, Lena Kask, Ramasri Sathanoori, Marloes Dekker-Nitert, Michael J. Kuhar, Bo Ahrén, Claes B. Wollheim, Ola Hansson, Anders Tengholm, Malin Fex, Erik Renström, Leif Groop, Valeriya Lyssenko, Nils Wierup

Erschienen in: Diabetologia | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Insufficient insulin release and hyperglucagonaemia are culprits in type 2 diabetes. Cocaine- and amphetamine-regulated transcript (CART, encoded by Cartpt) affects islet hormone secretion and beta cell survival in vitro in rats, and Cart ^−/− mice have diminished insulin secretion. We aimed to test if CART is differentially regulated in human type 2 diabetic islets and if CART affects insulin and glucagon secretion in vitro in humans and in vivo in mice.

Methods

CART expression was assessed in human type 2 diabetic and non-diabetic control pancreases and rodent models of diabetes. Insulin and glucagon secretion was examined in isolated islets and in vivo in mice. Ca²⁺ oscillation patterns and exocytosis were studied in mouse islets.

Results

We report an important role of CART in human islet function and glucose homeostasis in mice. CART was found to be expressed in human alpha and beta cells and in a subpopulation of mouse beta cells. Notably, CART expression was several fold higher in islets of type 2 diabetic humans and rodents. CART increased insulin secretion in vivo in mice and in human and mouse islets. Furthermore, CART increased beta cell exocytosis, altered the glucose-induced Ca²⁺ signalling pattern in mouse islets from fast to slow oscillations and improved synchronisation of the oscillations between different islet regions. Finally, CART reduced glucagon secretion in human and mouse islets, as well as in vivo in mice via diminished alpha cell exocytosis.

Conclusions/interpretation

We conclude that CART is a regulator of glucose homeostasis and could play an important role in the pathophysiology of type 2 diabetes. Based on the ability of CART to increase insulin secretion and reduce glucagon secretion, CART-based agents could be a therapeutic modality in type 2 diabetes.

Nur mit Berechtigung zugänglich

Ahrén B (2011) The future of incretin-based therapy: novel avenues—novel targets. Diabetes Obes Metab 13(Suppl 1):158–166CrossRefPubMed

Gromada J, Franklin I, Wollheim CB (2007) Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28:84–116CrossRefPubMed

D’Alessio D (2011) The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes Obes Metab 13(Suppl 1):126–132CrossRefPubMed

Groop L, Lyssenko V (2009) Genetic basis of beta-cell dysfunction in man. Diabetes Obes Metab 11(Suppl 4):149–158CrossRefPubMed

Ahrén B, Wierup N, Sundler F (2006) Neuropeptides and the regulation of islet function. Diabetes 55:S98–S107CrossRef

Douglass J, McKinzie AA, Couceyro P (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15:2471–2481PubMed

Rogge G, Jones D, Hubert GW, Lin Y, Kuhar MJ (2008) CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci 9:747–758CrossRefPubMedPubMedCentral

Kristensen P, Judge ME, Thim L et al (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72–76CrossRefPubMed

Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ (1998) CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29:293–298CrossRefPubMed

10.

Elefteriou F, Ahn JD, Takeda S et al (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514–520CrossRefPubMed

11.

Jensen PB, Kristensen P, Clausen JT et al (1999) The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans. FEBS Lett 447:139–143CrossRefPubMed

12.

Wierup N, Björkqvist M, Kuhar MJ, Mulder H, Sundler F (2006) CART regulates islet hormone secretion and is expressed in the beta-cells of type 2 diabetic rats. Diabetes 55:305–311CrossRefPubMed

13.

Wierup N, Kuhar M, Nilsson BO, Mulder H, Ekblad E, Sundler F (2004) Cocaine- and amphetamine-regulated transcript (CART) is expressed in several islet cell types during rat development. J Histochem Cytochem 52:169–177CrossRefPubMed

14.

Wierup N, Sundler F (2006) CART is a novel islet regulatory peptide. Peptides 27:2031–2036CrossRefPubMed

15.

Wierup N, Richards WG, Bannon AW, Kuhar MJ, Ahren B, Sundler F (2005) CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept 129:203–211CrossRefPubMed

16.

Wierup N, Gunnarsdottir A, Ekblad E, Sundler F (2007) Characterisation of CART-containing neurons and cells in the porcine pancreas, gastro-intestinal tract, adrenal and thyroid glands. BMC Neurosci 8:51CrossRefPubMedPubMedCentral

17.

Arciszewski MB, Calka J, Majewski M (2008) Cocaine- and amphetamine-regulated transcript (CART) is expressed in the ovine pancreas. Ann Anat 190:292–299CrossRefPubMed

18.

Sathanoori R, Olde B, Erlinge D, Göransson O, Wierup N (2013) Cocaine- and amphetamine-regulated transcript (CART) protects beta cells against glucotoxicity and increases cell proliferation. J Biol Chem 288:3208–3218CrossRefPubMed

19.

Asnicar MA, Smith DP, Yang DD et al (2001) Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142:4394–4400CrossRefPubMed

20.

del Giudice EM, Santoro N, Cirillo G, D’Urso L, Di Toro R, Perrone L (2001) Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes 50:2157–2160CrossRefPubMed

21.

Guerardel A, Barat-Houari M, Vasseur F et al (2005) Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population. BMC Genet 6:19CrossRefPubMedPubMedCentral

22.

Wierup N, Svensson H, Mulder H, Sundler F (2002) The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 107:63–69CrossRefPubMed

23.

Landerholm K, Shcherbina L, Falkmer SE, Järhult J, Wierup N (2012) Expression of cocaine- and amphetamine-regulated transcript is associated with worse survival in small bowel carcinoid tumors. Clin Cancer Res 18:3668–3676CrossRefPubMed

24.

Landerholm K, Falkmer SE, Järhult J, Sundler F, Wierup N (2011) Cocaine- and amphetamine-regulated transcript in neuroendocrine tumors. Neuroendocrinology 94:228–236CrossRefPubMed

25.

Mulder H, Lindh AC, Sundler F (1993) Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study. Cell Tissue Res 274:467–474CrossRefPubMed

26.

Vicentic A, Dominguez G, Hunter RG, Philpot K, Wilson M, Kuhar MJ (2004) Cocaine- and amphetamine-regulated transcript peptide levels in blood exhibit a diurnal rhythm: regulation by glucocorticoids. Endocrinology 145:4119–4124CrossRefPubMed

27.

Myrsen U, Ahrén B, Sundler F (1995) Neuropeptide Y is expressed in subpopulations of insulin- and non-insulin-producing islet cells in the rat after dexamethasone treatment: a combined immunocytochemical and in situ hybridisation study. Regul Pept 60:19–31CrossRefPubMed

28.

Hagenfeldt-Johansson KA, Herrera PL, Wang H, Gjinovci A, Ishihara H, Wollheim CB (2001) Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1 alpha induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology 142:5311–5320PubMed

29.

Ahrén J, Ahrén B, Wierup N (2010) Increased beta-cell volume in mice fed a high-fat diet: a dynamic study over 12 months. Islets 2:353–356CrossRefPubMed

30.

Rosengren AH, Jokubka R, Tojjar D et al (2010) Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327:217–220CrossRefPubMed

31.

De Marinis YZ, Salehi A, Ward CE et al (2010) GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab 11:543–553CrossRefPubMedPubMedCentral

32.

Dyachok O, Gylfe E (2004) Ca(2+)-induced Ca(2+) release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic beta-cells. J Biol Chem 279:45455–45461CrossRefPubMed

33.

Bergsten P, Grapengiesser E, Gylfe E, Tengholm A, Hellman B (1994) Synchronous oscillations of cytoplasmic Ca2+ and insulin release in glucose-stimulated pancreatic islets. J Biol Chem 269:8749–8753PubMed

34.

Liu YJ, Tengholm A, Grapengiesser E, Hellman B, Gylfe E (1998) Origin of slow and fast oscillations of Ca2+ in mouse pancreatic islets. J Physiol 508:471–481CrossRefPubMedPubMedCentral

35.

Tengholm A, Gylfe E (2009) Oscillatory control of insulin secretion. Mol Cell Endocrinol 297:58–72CrossRefPubMed

36.

Gilon P, Shepherd RM, Henquin JC (1993) Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets. J Biol Chem 268:22265–22268PubMed

37.

Gilon P, Henquin JC (1992) Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B cell. J Biol Chem 267:20713–20720PubMed

38.

Gilon P, Nenquin M, Henquin JC (1995) Muscarinic stimulation exerts both stimulatory and inhibitory effects on the concentration of cytoplasmic Ca2+ in the electrically excitable pancreatic B cell. Biochem J 311:259–267CrossRefPubMedPubMedCentral

39.

Vicentic A, Lakatos A, Jones D (2006) The CART receptors: background and recent advances. Peptides 27:1934–1937CrossRefPubMed

40.

Lv L, Jimenez-Krassel F, Sen A et al (2009) Evidence supporting a role for cocaine- and amphetamine-regulated transcript (CARTPT) in control of granulosa cell estradiol production associated with dominant follicle selection in cattle. Biol Reprod 81:580–586CrossRefPubMed

41.

Franklin I, Gromada J, Gjinovci A, Theander S, Wollheim CB (2005) Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 54:1808–1815CrossRefPubMed

42.

Schuit FC, Derde MP, Pipeleers DG (1989) Sensitivity of rat pancreatic A and B cells to somatostatin. Diabetologia 32:207–212CrossRefPubMed

Titel: CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion
verfasst von: Mia Abels
Matteo Riva
Hedvig Bennet
Emma Ahlqvist
Oleg Dyachok
Vini Nagaraj
Liliya Shcherbina
Rikard G. Fred
Wenny Poon
Maria Sörhede-Winzell
Joao Fadista
Andreas Lindqvist
Lena Kask
Ramasri Sathanoori
Marloes Dekker-Nitert
Michael J. Kuhar
Bo Ahrén
Claes B. Wollheim
Ola Hansson
Anders Tengholm
Malin Fex
Erik Renström
Leif Groop
Valeriya Lyssenko
Nils Wierup
Publikationsdatum: 23.06.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Diabetologia / Ausgabe 9/2016
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-016-4020-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2016

Coming of age: the artificial pancreas for type 1 diabetes

Can we make a better beta cell?

Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisation

Cocaine- and amphetamine-regulated transcript: a novel regulator of energy homeostasis expressed in a subpopulation of pancreatic islet cells

Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment

Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin